Page last updated: 2024-10-30

edaravone and Vestibular Diseases

edaravone has been researched along with Vestibular Diseases in 2 studies

Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.

Research Excerpts

ExcerptRelevanceReference
"Streptomycin was administered to the inner ear by osmotic pump for 24 h, and edaravone (n=8) or saline (n=6) was intraperitoneally injected once a day for 7 days."1.32Protective effect of edaravone against streptomycin-induced vestibulotoxicity in the guinea pig. ( Horiike, O; Ikeda, T; Shimogori, H; Yamashita, H, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horiike, O1
Shimogori, H2
Ikeda, T1
Yamashita, H2
Takemoto, T1
Mikuriya, T1

Other Studies

2 other studies available for edaravone and Vestibular Diseases

ArticleYear
Protective effect of edaravone against streptomycin-induced vestibulotoxicity in the guinea pig.
    European journal of pharmacology, 2003, Mar-07, Volume: 464, Issue:1

    Topics: Animals; Antipyrine; Edaravone; Guinea Pigs; Male; Nystagmus, Physiologic; Protective Agents; Reflex

2003
Edaravone protects the vestibular periphery from free radical-induced toxicity in response to perilymphatic application of (+/-)-alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid.
    European journal of pharmacology, 2007, Jan-12, Volume: 554, Issue:2-3

    Topics: Aldehydes; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipyrine; Edaravone;

2007